Takeda and Nanotherapeutics partner to expand influenza vaccine and other programs
Takeda Pharmaceutical Company Limited and Nanotherapeutics Inc. recently announced that they have made a partnership to grant Takeda further commercialization and technology access rights for a Vero cell technology platform from Nanotherapeutics. Read More »